Skip to main content
. Author manuscript; available in PMC: 2011 Jun 1.
Published in final edited form as: Obesity (Silver Spring). 2009 Oct 29;18(6):1201–1211. doi: 10.1038/oby.2009.360

Table 4.

Summary of significant genotype-intermediate phenotype associations

Entire cohort available Cohort with intermediate phenotype Δ Vol MTV Solid GE (t1/2) p-value

ADRA2C_Del322_325
ins/ins 200 52 487.9±13.7 1247.4 ± 40.8 123.5 ± 5.4 .0271 ↑(Solid GE)
ins/del; del/del 24; 0 10; 0 486.3±24.8 1060.5±113.7 101.8±7.5 .1136 ↓ (MTV)

ADRA2A-rs491589 CC 158 46 503.1±13.3 1207.6±48.2 117.7±5.0 .0395 ↓(ΔVol)
CT_TT 62; 4 14;2 449.0±23.8 1245.0±65.5 125.6±12.0

ADRA2A-rs553668 GG 157 45 503.1±13.3 1210.8±49.2 117.6±5.1 .0395 ↓ (ΔVol)
AG_AA_ 62; 5 15;2 449.0±23.8 1234.4±62.4 125.6±11.2

ADRA2A-rs3750625 CC 200 55 477.6±12.5 1216.8±42.0 122.7±5.1 .0275 ↑ (ΔVol)
AC_AA 23; 1 7;0 559.8±27.5 1220.9±121.5 94.8±10.1

ADRA2A-rs34665740 AA 209 57 480.9±12.6 1223.9±41.8 120.5±5.1 .0900 ↑ (ΔVol)
AC_CC 14; 1 5;0 547.2±33.6 1141.0±113.0 109.9±12.8

UCP_2 +347445bp-insdel
ins/ins 111 31 498.5±18.1 1217.9±48.5 112.1±5.7 All p>0.15
ins/del; del/del 98;15 28;3 475.3±15.7 1216.6±62.9 126.9±7.5

UCP_3-rs590336 TT 62 16 462.4±17.5 1055.3±62.3 130.1±11.1 .0750 ↑ (MTV)
CT_ CC 124;38 38;8 496.7±15.0 1273.6±45.9 115.8±5.1

UCP_3-rs1685356 CC 69 19 480.7±17.6 1044.3±53.6 127.0±10.1 .0261 ↑ (MTV)
CT_ TT 118;37 35; 8 491.0±15.9 1293.7±47.4 116.5±5.3

UCP_3-rs11235971 TT 110 29 513.2±15.9 1244.3±55.6 115.1±6.5 .0676 ↓ (ΔVol)
CT_ CC 101;13 30;3 466.8±16.9 1193.1±56.0 124.1±7.0

UCP_3-rs2075577 TT 73 18 456.6±16.4 1024.4±59.3 128.4±10.4 .0805 ↑ (ΔVol)
CT_ TT 122;29 37;7 501.3±15.4 1296.1±45.1 115.9±5.1 .0058 ↑ (MTV)

GNB3-rs2269355 CC 74 26 517.2±17.0 1196.9±68.2 126.7±8.3 .0212 ↓ (ΔVol)
CG_GG 112; 38 23;13 463.5±15.8 1232.0±47.3 114.9±5.7

GNB3-rs10849527 CC 116 35 512.9±15.0 1213.9±55.7 124.4±6.8 .0029 ↓ (ΔVol)
CT_ TT 90; 18 22;5 456.6±17.8 1221.6±55.5 114.1±6.6

GNB3-rs3759348 CC 116 32 508.3±16.9 1231.8±60.4 119.3±7.3 .0156↓ (ΔVol)
CT_TT 91; 17 25;5 454.2±16.2 1201.7±50.5 120.3±6.4

GNB3-rs4963517 CC 67 20 449.7±22.6 1188.4±54.8 109.6±7.3 .0288 ↑ (ΔVol)
CT_ TT 116; 41 30; 12 504.4±13.5 1231.0±52.2 124.7±6.1

GNB3-rs1129649 TT 99 24 521.5±18.8 1238.8±73.1 123.0±9.2 .0021 ↑ (ΔVol)
CC_CT 99;26 30;8 462.2±14.2 1203.7±45.4 117.9±5.5

GNB3-rs1047776 GG 190 54 480.5±13.0 1205.8±42.6 116.1±4.3 .0042 ↓ (Solid GE)
AG_AA 34;0 8; 0 524.3±30.3 1294.6±105.0 151.7±26.0

GNB3-rs5440 GG 51 19 452.8±26.5 1196.7±53.5 118.6±8.6 All p>0.15
AA_AG 63;110 17; 26 500.2±13.0 1226.3±51.9 120.3±5.8

GNB3-rs5443 (C825T) CC 108 29 500.4±17.6 1307.0±66.0 122.6±8.7 All p>0.15
CT_TT 100;16 30;3 472.0±15.7 1138.4±42.3 117.7±5.4

FTO-rs9939609 AA 48 17 508.0±20.1 1372.8±80.6 108.8±8.0 .0075 ↑ (MTV)
TT_ AT 73;10 16;29 480.3±14.7 1158.5±42.2 124.0±5.8

5_HTTLPR LL 70 23 478.9±19.5 1118.7±62.9 124.3±7.1 .1059 ↑ (MTV)
LS_SS 109; 45 29; 10 491.9±15.3 1275.4±48.6 117.2±6.4

Δ Vol=difference between postprandial and fasting gastric volume,

MTV=maximum tolerated volume during nutrient drink test,

GE=gastric emptying

↑ = acceleration of gastric emptying rate or increased volume (MTV or Δ Vol),

↓ = delay in gastric emptying rate, or decreased volume

=for test of association of response with genotype categories from the ANCOVA (adjusting for age and gender); unless otherwise stated, p>0.15

HHS Vulnerability Disclosure